Obagi Nu-Derm Blend Fx | Brightening Cream | 57g

Product Overview - Obagi Nu-Derm Blend Fx 57g. Obagi Nu-Derm Blend Fx is a professional-grade brightening cream expertly formulated to transform hyperpigmented skin at the cellular level. This hydroquinone-free formula combines 7% Arbutin, a nature-identical skin brightening agent, with Lactic Acid (an alpha hydroxy acid) to deliver comprehensive skin tone correction. As step 5 in the clinically-proven Obagi Nu-Derm Fx System, this rich nighttime treatment addresses dark spots, sunspots, age spots, and melasma whilst promoting healthy cell turnover and supporting collagen production.. Suitable for all skin types including sensitive skin, this advanced formulation has been designed to work synergistically with retinoids, enhancing their absorption and efficacy. The cream's unique blend of Ascorbic Acid (Vitamin C) and Tocopheryl Acetate (Vitamin E) provides powerful antioxidant protection whilst the gentle exfoliating action reveals a more luminous, even-toned complexion.. Key Benefits at a Glance:. Immediate Benefits:. Brightens and clarifies the complexion by targeting uneven skin tone and discolouration. Gently exfoliates the skin's surface, promoting healthy cell turnover and removing dull, damaged cells. Hydrates and nourishes whilst working overnight to restore skin radiance. Enhances retinoid absorption when mixed together, maximising the efficacy of your skincare regime. Provides antioxidant protection against environmental damage with Vitamins C and E. Long-Term Benefits:. With consistent use as part of your evening skincare routine, Obagi Nu-Derm Blend Fx helps to significantly reduce the appearance of stubborn hyperpigmentation, dark spots, and melasma caused by sun damage, hormonal changes, or post-inflammatory concerns. The formula works progressively to reveal younger, healthier-looking skin by supporting natural collagen production and improving overall skin texture and elasticity.. Over time, you can expect a more balanced, luminous complexion with vi